Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Acetamidophenylboronic acid → N-{4-[6-(4-Cyclopropyl-[1,4]diazepan-1-yl)pyridazin-3-yl]phenyl}acetamide, dihydrochloride
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Acetamidophenylboronic acid | HCID 2734657 | — |
| 반응물 | 1-(6-Chloro-pyridazin-3-yl)-4-cyclopropyl-perhydro-1,4-diazepine | HCID 87286183 | — |
| 생성물 | N-{4-[6-(4-Cyclopropyl-[1,4]diazepan-1-yl)pyridazin-3-yl]phenyl}acetamide, dihydrochloride | HCID 131730780 | — |
반응 단계
The title compound was prepared by a similar procedure to that described in Example 68, starting from 1-(6-chloro-pyridazin-3-yl)-4-cyclopropyl-perhydro-1,4-diazepine and 4-acetamidophenylboronic acid. 1H NMR (400 MHz, CD3OD) δ 8.47 (d, 1H), 8.08 (d, 1H), 7.94 (d, 2H), 7.85 (d, 2H), 4.33 (broad m, 1H), 4.12 (broad m, 1H), 3.91 (broad m, 4H), 3.62 (broad m, 2H), 2.97 (hept, 1H), 2.55 ((broad m, 1H), 2.43 (broad m, 1H), 2.17 (s, 3H), 1.24 (broad m, 2H), 1.01 (d, 2H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08846677B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-8a4d099e74044e5986736d68ebe9a625 |
| 출처 메모 | uspto-grants-2014_09 |